IP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
International Paper Co is not a strong buy for a beginner, long-term investor at this moment. The stock lacks immediate bullish signals from technical indicators, options sentiment, and trading signals. While the acquisition of North Pacific Paper Company is a positive catalyst, the company's financial performance, particularly its negative net income and EPS, along with mixed analyst ratings and reduced price targets, suggest caution. Holding the stock or waiting for better entry points is advisable.
The MACD is positive but contracting, indicating weakening bullish momentum. RSI is neutral at 48.952, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 35.757, with resistance at 37.078 and support at 34.435. Overall, technical indicators do not suggest a strong buy signal.
The acquisition of North Pacific Paper Company for $360 million is a strategic move to enhance market share, production capabilities, and competitive positioning in sustainable packaging. Additionally, capacity reductions in North American containerboard producers are improving the pricing environment.
The company faces challenges such as elevated energy and freight costs, rising fiber costs, and oversupplied boxboard markets. Analyst ratings and price targets have been consistently lowered, reflecting demand uncertainty and cost pressures. Financial performance shows a significant net income loss and declining gross margins.
In Q4 2025, revenue increased by 53.14% YoY to $6.006 billion. However, net income was -$2.384 billion, a significant loss despite a 1521.77% YoY improvement. EPS was -4.51, up 902.22% YoY, but still negative. Gross margin dropped to 19.66%, down 17.64% YoY, indicating cost pressures.
Analysts have mixed ratings, with some maintaining Buy ratings but lowering price targets due to cost pressures and market challenges. The average price target has been reduced, with the most recent targets ranging from $38 to $48. UBS downgraded the stock to Neutral, citing prolonged transformation costs and cost headwinds extending into 2027.
